ELEVATION ONCOLOGY INC (ELEV)

US28623U1016 - Common Stock

3.7  -0.12 (-3.14%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
40.34M94.55M32.05M17.28M5.88M
Research and Development
25.43M78.72M23.60M15.48M5.34M
Selling, General, and Administrative Expenses
14.90M15.83M8.45M1.80M540.00K
Operating Income
-40.34M-94.55M-32.05M-17.28M-5.88M
Interest Income/Expense
-4.20M-1.50MN/AN/AN/A
Other Income/Expense
3.97M990.00K10.00K10.00K0.00
Non Recurring Items
-5.11MN/AN/AN/AN/A
Income Before Taxes
-45.67M-95.06M-32.04M-17.27M-5.88M
Income Tax
30.00K30.00KN/AN/AN/A
Net Income
-45.70M-95.08M-32.04M-17.27M-5.88M
EBITDA
-40.30M-94.52M-32.03M-17.26MN/A
 
Per Share Data
EPS Diluted Total Ops
-1.34-4.09-2.64-0.76-0.26
Non GAAP EPS
-1.53-4.09N/AN/AN/A
 
Statistics

All data in USD

Charts